Average Co-Inventor Count = 4.74
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (67 from 725 patents)
68 patents:
1. 12098183 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
2. 12065477 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
3. 11919940 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
4. 11858978 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
5. 11840562 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
6. 11819518 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
7. 11806366 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
8. 11559550 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
9. 11560405 - Peptides and combination thereof for use in the immunotherapy against cancers
10. 11542303 - Peptides and combination thereof for use in the immunotherapy against cancers
11. 11427614 - Peptides and combination thereof for use in the immunotherapy against cancers
12. 11345737 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
13. 11278571 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
14. 11246889 - Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
15. 11248035 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers